The World Health Organisation said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug that US President Trump says he is taking — from its global study into experimental Covid-19 treatments, saying that...
Full ArticleCovid 19 coronavirus: UN virus therapy trial pauses hydroxychloroquine testing
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: American Manganese, Bragg Gaming, Gold Resource, Phunware UPDATE …
Proactive Investors
American Manganese Inc (CVE:AMY) (OTCMKTS:AMYZF) is extending the exercise period of nearly 5.3 million warrants exercisable at..
-
VolitionRx CEO to present coronavirus white blood cell research at Maxim Group virtual conference
Proactive Investors
-
NA Proactive news snapshot: Zynerba Pharmaceuticals, Loop Insights, Talon Metals, Pacton Gold …
Proactive Investors
-
NA Proactive news snapshot: Genprex, PyroGenesis Canada, Internet of Things, Ozop Surgical, Zynerba Pharmaceuticals UPDATE …
Proactive Investors
-
WHO pauses hydroxychloroquine from drug study, warns of possible "second peak" of coronavirus
CBS News
Advertisement
More coverage
WHO pauses trial of hydroxychloroquine, once touted by Trump as a ‘game changer,’ over safety concerns
Seattle Times
For months, President Donald Trump has promoted hydroxychloroquine as a potential treatment for COVID-19, calling the anti-malarial..
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors
-
U.N. COVID-19 Therapy Trial Pauses Hydroxychloroquine Testing Due to Report of Higher Death Risk
TIME
-
UN virus therapy trial pauses hydroxychloroquine testing
SeattlePI.com
-
UN trial for virus therapies pauses testing on Trump's drug
CTV News